All News

cost.healthcare.jpg

Price of Drug Promotion Skyrockets

d Jack Cush, MD

JAMA reports that health care advertising costs in the U.S. have almost doubled over the past two decades, surging from $17.7 billion in 1997 to at least $29.9 billion in 2016.

Read Article
preg.infertility.jpg

Combo RA Treatment May Boost Risk for Serious Adverse Events

d RheumNow

A current meta-analysis of safety and efficacy of combination bDMARD treatment in RA patients shows that combination treatments increase serious advese event (SAE) risks, and the risk for serious infections in particular.

Read Article
overdose.narcotic.jpg

Opioids Double Rates of Suicides and Overdoses

d Jack Cush, MD

An article in the New England Journal of Medicine reports that the rates of suicide and drug overdoses has doubled in the last 17 years, and that opioids are largely to blame.

Read Article
moneyglobe.jpg

BMS Buyout of Celgene for $74 Billion

d Jack Cush, MD

Reuters reports that Bristol-Myers Squibb (BMS) has announced its intention to buy Celgene Corp for nearly $74 billion in a cash-and-stock deal.

Read Article
RN.podcast.resized.jpg

RheumNow Podcast – A Grand New Year (1.4.19)

d Jack Cush, MD

Dr. Jack Cush reviews the news and journals for the beginning of 2019. All from RheumNow.com.

Best wishes for a charmed 2019! My advice: 1. Just show up. 2. If you can, then you must do. 3. Live each day as if it twas your 1st day/last day/make or break day. 4. Teach.

Read Article
2018.jpeg

2018 Rheumatology Year In Review

d Jack Cush, MD

This annual appraisal of hallmark moments, news and research articles from 2018 are gleaned from that published in RheumNow during the last year and filtered by other news sources and literature review.  The top 10 list herein is rooted in what rheumatologists should know and what will likel

Read Article
knee2_0.JPG (keep)

Uncertain Long Term Efficacy in Trials of Knee Osteoarthritis

d Jack Cush, MD

A systematic review and network meta-analysis of 47 randomized clinical trials in knee osteoarthritis finds uncertainty around estimates of effect size for pain scores thereby casting uncertainty over the long-term efficacy of medications for knee osteoarthritis.

Read Article
QD Video from RheumNow - these are daily lessons from the arthritis clinic. Here Dr. Cush discusses what to call seronegative inflammatory arthritis. https://t.co/f7LlwUU0aq

Links:

Dr. John Cush RheumNow ( View Tweet)

QD Video from RheumNow - Dicusssion of statins and myalgias/arthralgias. https://t.co/zKFZEF6MiL

Links:

Dr. John Cush RheumNow ( View Tweet)

Medicare claims analysis shows that older ankylosing spondylitis patients have a 2 fold increased risk of THAT and TKA (R R 2.14, 95% CI 1.93–2.38). https://t.co/HVFFQNTmdz

Links:

Dr. John Cush RheumNow ( View Tweet)

Obesity makes everything worse, including SLE! Study of 148 SLE pts; the 32% who were obese had worse disease activity, depression, pain and fatigue. https://t.co/PQOQrBca2a

Links:

Dr. John Cush RheumNow ( View Tweet)

Rheumatology Year in Review - New Drugs, irAEs, Enbrel in court, Opioids, new JAKs, Hot PsA Trial, new Lupus drugs, Medical Marijuana, Expen$ive Rheum drugs, Senolytics. https://t.co/9VpM4yRGfY

Links:

Dr. John Cush RheumNow ( View Tweet)

RheumNow Weekly Podcast is up - watch here: https://t.co/vAtEYSPIhG or listen on iTunes or here https://t.co/D3n7so7mN9

Links:

Dr. John Cush RheumNow ( View Tweet)

Potential Blockbuster Takeover - BMS proposal to takeover Celgene for $74 Billion! Bristol-Myers' acquisition of Celgene would rank among the industry's largest ever. https://t.co/hWuygShcNq

Links:

Dr. John Cush RheumNow ( View Tweet)

Learn about the pathophysiology, assessment & treatment of #psoriatic #dactylitis in our new #Perspectives article Now online at https://t.co/ewqx3xdXTz #PsoriaticArthritis #Arthritis #Enthesitis https://t.co/2bkHgKNGPQ

Links:

NatRevRheumatol NatRevRheumatol ( View Tweet)
Happy birthday to the US Public Health Service Commissioned Corps. I’m proud of my colleagues who continue the Commissioned Corps’ 130-year legacy as the frontline defender of public health, providing critical health expertise and rapid response to public health emergencies.

Secretary Alex Azar SecAzar ( View Tweet)

2018 Rheumatology Year In Review | RheumNow - Rheumatology News & Information https://t.co/zo1AaWZ0MR

Links:

Dr. John Cush RheumNow ( View Tweet)

FDA warns fluoroquinolone use may increase risk ofruptures or tears in the aorta. Thus Fluoroquinolones should not be used w/ aortic aneurysms, peripheral vascular Dz, HTN, Marfans/Ehlers-Danlos, or the elderly, unless there are no other options available https://t.co/aTEE0keIS8

Links:

Dr. John Cush RheumNow ( View Tweet)

Finnish followup study of 68,800 hip fracture pts w hip surgery finds 4.6% w/ complications - esp with heavy alcoholism (HR 1.38); Parkinson’s (1.22); osteoarthritis (2.02); rheumatic Dz (1.44); those w/ depression/psychosis, operative delay, prior THR https://t.co/StahnHXRuZ

Links:

Dr. John Cush RheumNow ( View Tweet)

Chronic Urticaria associated with a 23% higher risk of osteoporosis, irrespective of steroid use. Population study from Israel compared 11,944 Chr urticaria w/ 59,829 controls. (HR = 1.23, 95% CI 1.10–1.37, p <0.001) https://t.co/eSq4BPV2J4

Links:

Dr. John Cush RheumNow ( View Tweet)

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2024 All Rights Reserved.

×